These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24435307)

  • 1. TUSC3 loss alters the ER stress response and accelerates prostate cancer growth in vivo.
    Horak P; Tomasich E; Vaňhara P; Kratochvílová K; Anees M; Marhold M; Lemberger CE; Gerschpacher M; Horvat R; Sibilia M; Pils D; Krainer M
    Sci Rep; 2014 Jan; 4():3739. PubMed ID: 24435307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of the oligosaccharyl transferase subunit TUSC3 promotes proliferation and migration of ovarian cancer cells.
    Vaňhara P; Horak P; Pils D; Anees M; Petz M; Gregor W; Zeillinger R; Krainer M
    Int J Oncol; 2013 Apr; 42(4):1383-9. PubMed ID: 23404293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TUSC3: functional duality of a cancer gene.
    Vašíčková K; Horak P; Vaňhara P
    Cell Mol Life Sci; 2018 Mar; 75(5):849-857. PubMed ID: 28929175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor candidate 3 (TUSC3) prevents the epithelial-to-mesenchymal transition and inhibits tumor growth by modulating the endoplasmic reticulum stress response in ovarian cancer cells.
    Kratochvílová K; Horak P; Ešner M; Souček K; Pils D; Anees M; Tomasich E; Dráfi F; Jurtíková V; Hampl A; Krainer M; Vaňhara P
    Int J Cancer; 2015 Sep; 137(6):1330-40. PubMed ID: 25735931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour suppressor candidate 3 inhibits biological function and increases endoplasmic reticulum stress of melanoma cells WM451 by regulating AKT/GSK3-β/β-catenin pathway.
    Wang S; Zhu W
    Cell Biochem Funct; 2020 Jul; 38(5):604-612. PubMed ID: 32090352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TUSC3 suppresses glioblastoma development by inhibiting Akt signaling.
    Jiang Z; Guo M; Zhang X; Yao L; Shen J; Ma G; Liu L; Zhao L; Xie C; Liang H; Wang H; Zhu M; Hu L; Song Y; Shen H; Lin Z
    Tumour Biol; 2016 Sep; 37(9):12039-12047. PubMed ID: 27177902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of substrate specificity of human oligosaccharyl transferase subunit N33/Tusc3 and its role in regulating protein N-glycosylation.
    Mohorko E; Owen RL; Malojčić G; Brozzo MS; Aebi M; Glockshuber R
    Structure; 2014 Apr; 22(4):590-601. PubMed ID: 24685145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TUSC3 induces drug resistance and cellular stemness via Hedgehog signaling pathway in colorectal cancer.
    Ren Y; Deng R; Cai R; Lu X; Luo Y; Wang Z; Zhu Y; Yin M; Ding Y; Lin J
    Carcinogenesis; 2020 Dec; 41(12):1755-1766. PubMed ID: 32338281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Insight into the Mechanism of
    Mohanty S; Chaudhary BP; Zoetewey D
    Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32316603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA-mediated TUSC3 deficiency enhances UPR and ERAD to promote metastatic potential of NSCLC.
    Jeon YJ; Kim T; Park D; Nuovo GJ; Rhee S; Joshi P; Lee BK; Jeong J; Suh SS; Grotzke JE; Kim SH; Song J; Sim H; Kim Y; Peng Y; Jeong Y; Garofalo M; Zanesi N; Kim J; Liang G; Nakano I; Cresswell P; Nana-Sinkam P; Cui R; Croce CM
    Nat Commun; 2018 Nov; 9(1):5110. PubMed ID: 30504895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TUSC3 inhibits cell proliferation and invasion in cervical squamous cell carcinoma via suppression of the AKT signalling pathway.
    Sun F; Jie Q; Li Q; Wei Y; Li H; Yue X; Ma Y
    J Cell Mol Med; 2022 Mar; 26(5):1629-1642. PubMed ID: 35137520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased TUSC3 Promotes Pancreatic Cancer Proliferation, Invasion and Metastasis.
    Fan X; Zhang X; Shen J; Zhao H; Yu X; Chen Y; Zhuang Z; Deng X; Feng H; Wang Y; Peng L
    PLoS One; 2016; 11(2):e0149028. PubMed ID: 26871953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-873-5p inhibits the progression of colon cancer via repression of tumor suppressor candidate 3/AKT signaling.
    Zhu Y; Zhang X; Qi M; Zhang Y; Ding F
    J Gastroenterol Hepatol; 2019 Dec; 34(12):2126-2134. PubMed ID: 31039290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TUSC3 accelerates cancer growth and induces epithelial-mesenchymal transition by upregulating claudin-1 in non-small-cell lung cancer cells.
    Feng S; Zhai J; Lu D; Lin J; Dong X; Liu X; Wu H; Roden AC; Brandi G; Tavolari S; Bille A; Cai K
    Exp Cell Res; 2018 Dec; 373(1-2):44-56. PubMed ID: 30098333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling.
    Conley-LaComb MK; Saliganan A; Kandagatla P; Chen YQ; Cher ML; Chinni SR
    Mol Cancer; 2013 Jul; 12(1):85. PubMed ID: 23902739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IQGAP2, A candidate tumour suppressor of prostate tumorigenesis.
    Xie Y; Yan J; Cutz JC; Rybak AP; He L; Wei F; Kapoor A; Schmidt VA; Tao L; Tang D
    Biochim Biophys Acta; 2012 Jun; 1822(6):875-84. PubMed ID: 22406297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Interactome Analysis Reveals that STT3B Is Required for N-Glycosylation of Lassa Virus Glycoprotein.
    Zhu S; Wan W; Zhang Y; Shang W; Pan X; Zhang LK; Xiao G
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic function of TUSC3 in non-small cell lung cancer is associated with Hedgehog signalling pathway.
    Gu Y; Pei X; Ren Y; Cai K; Guo K; Chen J; Qin W; Lin M; Wang Q; Tang N; Cheng Z; Ding Y; Lin J
    Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1749-1760. PubMed ID: 28487226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCMV-encoded miR-UL112-3p promotes glioblastoma progression via tumour suppressor candidate 3.
    Liang Q; Wang K; Wang B; Cai Q
    Sci Rep; 2017 Mar; 7():44705. PubMed ID: 28303930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammalian cells lacking either the cotranslational or posttranslocational oligosaccharyltransferase complex display substrate-dependent defects in asparagine linked glycosylation.
    Cherepanova NA; Gilmore R
    Sci Rep; 2016 Feb; 6():20946. PubMed ID: 26864433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.